Patel SK; Ma CS; Fourlanos S; Greenfield JR, 2026, 'Clinical, immunogenetic and metabolic characteristics of autoantibody-negative and autoantibody-positive type 1 diabetes', Diabetologia, 69, pp. 600 - 609, http://dx.doi.org/10.1007/s00125-025-06580-7
Journal articles | 2024
Patel SK; Fourlanos S; Greenfield JR, 2024, 'Atypical Diabetes: What Have We Learned and What Does the Future Hold? Diabetes Care 2024;47:770–781', Diabetes Care, 47, http://dx.doi.org/10.2337/dc24-1388
Journal articles | 2024
Patel SK; Fourlanos S; Greenfield JR, 2024, 'Classification of type 1 diabetes: A pathogenic and treatment-based classification', Diabetes and Metabolic Syndrome Clinical Research and Reviews, 18, http://dx.doi.org/10.1016/j.dsx.2024.102986
Journal articles | 2022
Patel SK; Ma CS; Bell KJ; Oram R; Hagopian WA; Fourlanos S; Greenfield JR, 2022, 'Immunophenotype and genetic risk scores to improve autoantibody negative type 1 diabetes classification: study protocol', International Journal of Clinical Trials, 9, pp. 293 - 293, http://dx.doi.org/10.18203/2349-3259.ijct20222690
Journal articles | 2021
Chi C; Patel S; Cheung NW, 2021, 'Admission sodium levels and hospital outcomes.', Intern Med J, 51, pp. 93 - 98, http://dx.doi.org/10.1111/imj.14777
Journal articles | 2021
Heidegger DP; Neal KE; Patel SK; Greenfield JR; Tonks KT, 2021, 'Effect of fasting ketosis and type 1 diabetes on alcohol breath analysis technology used in Australia', Internal Medicine Journal, 51, pp. 1555 - 1556, http://dx.doi.org/10.1111/imj.15488
Journal articles | 2021
Patel SK; Fourlanos S; Greenfield JR, 2021, 'Comment on ‘impact of routine Clinic Measurement of random Serum c-peptide in people with a Clinician Diagnosis of type 1 diabetes’', Diabetic Medicine, 38, http://dx.doi.org/10.1111/dme.14513
Journal articles | 2021
Patel SK; Ma CS; Fourlanos S; Greenfield JR, 2021, 'Autoantibody-Negative Type 1 Diabetes: A Neglected Subtype', Trends in Endocrinology and Metabolism, 32, pp. 295 - 305, http://dx.doi.org/10.1016/j.tem.2021.02.001
Journal articles | 2019
Patel S; Chin V; Greenfield JR, 2019, 'Durvalumab-induced diabetic ketoacidosis followed by hypothyroidism', Endocrinology Diabetes and Metabolism Case Reports, 2019, http://dx.doi.org/10.1530/EDM-19-0098
